Daxor Corporation has introduced its ezBVA Lab diagnostic service for outpatient blood volume analysis at a healthcare facility in eastern Kansas. This service offers clinicians precise, 98% accurate blood volume measurements within 24 hours without the need for capital equipment or lab infrastructure. By providing objective data on blood, plasma, and red cell volume, the service helps optimize patient treatment, reduce hospital readmissions, and lower healthcare costs. This expansion strengthens Daxor's presence in the Midwest and supports value-based care improvements.
The iShares US Small Cap Value Factor ETF (SVAL) remains rated as Hold due to its portfolio's heavy financial sector exposure and a strong 6.8% earnings yield, which is 1.7 times higher than the broader market ETF IVV. However, the fund shows persist...
Uniswap founder Hayden Adams revealed that Sam Bankman-Fried (SBF) paid a seven-figure sum for the Uniswap.com domain after Uniswap Labs declined the seller's price. The domain had been redirecting visitors to SushiSwap, a competing decentralized exc...
ZetaChain token holders voted overwhelmingly (99.4%) to shut down the project's independent Layer 1 blockchain and migrate ZETA tokens to Solana as native SPL tokens. The migration will convert tokens on a 1:1 basis, with a change in decimal precisio...
The Vanguard International High Dividend Yield ETF (VYMI) maintained positive absolute returns even as US economic growth rebounded strongly and the Federal Reserve confirmed a higher-for-longer interest rate stance. This environment compressed valua...
A class action lawsuit has been filed against Dun & Bradstreet Holdings, Inc. concerning its merger with Clearlake Capital Group affiliates. The suit alleges that Dun & Bradstreet provided false and misleading information in its merger announcement a...
